Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-04-17
2007-04-17
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S215000, C548S235000
Reexamination Certificate
active
10833721
ABSTRACT:
Compounds of formula (I)are useful in the therapy and/or prevention of illnesses with known over-expression of receptor tyrosine kinases of the HER-family like HER-2 and EGFR (HER-1). Accordingly, these compounds are useful for the treatment of diseases such as cancer in humans or animals.
REFERENCES:
patent: 6211215 (2001-04-01), Momose et al.
patent: 2002/0173526 (2002-11-01), Tasaka et al.
patent: 1 270 571 (2003-01-01), None
patent: WO 98/03505 (1998-01-01), None
patent: WO 01/77107 (2001-10-01), None
Baselga et al., Oncology, 63, pp. 6-16 (2002).
Chan et al., Curr. Opin. Immunol., 8, pp. 394-401 (1995).
Wilks, A. F., Progress in Growth Factor Research, 2, pp. 97-111 (1990).
Wright et al., Br. J. Cancer, 65, pp. 118-121 (1992).
Bossenmaier Birgit
Friebe Walter-Gunar
Reiff Ulrike
Rueth Matthias
Voss Edgar
Hoffmann-La Roche Inc.
Johnston George W.
Remy Brian C.
Rocha-Tramaloni Patricia S.
Shameem Golam M. M.
LandOfFree
Aniline derivatives, their manufacture and use as... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aniline derivatives, their manufacture and use as..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aniline derivatives, their manufacture and use as... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3779526